Article
miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1
26 Jan 2018
Abstract excerpt
PURPOSE: Increasing evidence shows that altered metabolism is a critical hallmark in colon cancer. There is a strong need to explore the molecular mechanisms underlying cancer metabolism. Whether the aberrant expression of microRNAs contributes to cancer metabolism is not fully understood. miR-328 is a putative potential target of SLC2A1, but the regulating mechanism between them remains unknown. We have examined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
